National Storage Mechanism | Additional information

1 November 2022

U.K. SPAC PLC

("The Company")

Letter to Shareholders of the Company

I am delighted to be able to tell you that as the final version of the prospectus has now been submitted for sign off by the FCA our focus has moved to finalising the work (which is already well advanced) required for the completion of the UK SPAC/Hellenic RTO and the admission of the shares to trading on the Main Market of the London Stock Exchange.

Even though the transaction may have been a lengthy and complex one (because Hellenic will be the first cultivator of medicinal cannabis to obtain a listing on the Main Market) the directors of the two companies have throughout retained their confidence in the project and the benefits that it can bring to the shareholders of both companies. They are extremely grateful for the work over the last eighteen months by the excellent team of advisers and brokers.

You will shortly receive a copy of the prospectus together with the notice of the general meeting to approve the resolutions necessary to enable the Company to complete the RTO process and confirmation of the completion date.

Peter Jay

Chairman

UK SPAC PLC 07500 558235

Peterhouse Capital Limited

Lucy Williams / Duncan Vasey 020 7469 0930

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END